Efficacy and Safety of Dual Targeted Therapy Using Biologics and Small Molecules for Psoriasis and Comorbidities: A Systematic Review

Abstract

Keywords

psoriasis dual biologic therapy Janus kinase inhibitors phosphodiesterase-4 inhibitors systematic review

Get full access to this article

View all access options for this article.

References

Girolomoni

Strohal

Puig

, et al. The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(10):1616-1626. doi:10.1111/jdv.14433

Chiu

Cheng

Tsai

TF.

T helper type 17 in psoriasis: from basic immunology to clinical practice. Dermatol Sin. 2012;30(4):136-141. doi:10.1016/j.dsi.2012.08.002

Diani

Altomare

Reali

T helper cell subsets in clinical manifestations of psoriasis. J Immunol Res. 2016;2016:7692024. doi:10.1155/2016/7692024

Rendon

Schäkel

Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475. doi:10.3390/ijms20061475

Guo

Zhang

Lin

Chen

Signaling pathways and targeted therapies for psoriasis. Signal Transduct Target Ther. 2023;8(1):437. doi:10.1038/s41392-023-01655-6

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.12 MB